@5cata and Mozzarc - Thank you very much. I guess if/when it is approved and starts to earn a lot of money, big pharma will throw everything into trying to replicate it, but holders of Paradigm will have been rewarded by a tremendous increase in share price by then.
The novel drug - A DMOAD approach, page-22
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $114.9K | 583.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 46251 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 185907 | 7 |
View Market Depth
| Last trade - 14.05pm 09/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |